O-4 GEMSTONE-304: A phase 3 study of sugemalimab plus chemotherapy versus chemotherapy as first-line treatment of patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC)
Titel:
O-4 GEMSTONE-304: A phase 3 study of sugemalimab plus chemotherapy versus chemotherapy as first-line treatment of patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC)
Auteur:
Li, J. Chen, Z. Bai, Y. Liu, B. Li, Q. Zhou, J. Zhang, J. Deng, T. Zhou, F. Gao, S. Yang, S. Ye, F. Chen, L. Bai, W. Yin, X. Xu, Y. Hu, J. Ni, J. Wang, B. Yang, J.